Dr. Mary Catherine Catherine Mayo, MD

Dr. Mayo practices at Regents of the University of California Los Angeles in Santa Monica, California.

Dr. Mayo's NPI, 1922326735, was assigned on May 5, 2010. Dr. Mayo graduated from Keck School of Medicine of USC in 2010. Dr. Mayo holds California license 120511.

Dr. Mayo's primary practice is Regents of the University of California Los Angeles, at 1801 Wilshire Blvd, Santa Monica, CA 90403 in Los Angeles County. The practice phone is (310) 391-7281.

Dr. Mayo's primary practice is Regents of the University of California Los Angeles in Santa Monica, California. Dr. Mayo is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Neurology. Dmand AI also links Dr. Mayo to 1 more hospital, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mayo practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Mayo's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Mayo is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Mayo is licensed in California.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, encephalopathy, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Dr. Mayo treats.

CMS data shows 7,938 Medicare services from Dr. Mayo across 6 procedure codes in 2024, for 390 Medicare patients. Medicare paid $142,109 for them. Every service was in an office.

CMS counts 390 Medicare patients who saw Dr. Mayo in 2024. The largest group is 75 to 84, with 160 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mayo's median patient age at 68, with 62% women.

In 2024, Dr. Mayo wrote 1,994 Medicare Part D claims for 372 patients. 89% of them were for generic drugs. CMS names the drug for 1,827 of them, across 39 drugs with 11 or more claims each, at $465,352 in total drug cost. In 2023, CMS named 1,693 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Mayo for performance year 2024, reported as part of a group. Dr. Mayo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mayo as offering telehealth.

Dmand AI links 10 papers to Dr. Mayo, published from 2006 to 2014. The most frequent topics are Cell Line, Transcription, Genetic and Binding Sites. Dr. Mayo has published most often in Oncogene. Dr. Mayo's most frequent co-authors are Soonmee Cha, MD, Mitchel S. Berger, MD and Adam L. Boxer, MD.

CMS Open Payments shows 182 general payments to Dr. Mayo from 29 drug and device companies from 2016 to 2025. Grants make up the largest share, 62% of the total. Medtronic USA, Inc. paid the most, $6,271.

Dr. Mayo graduated from Keck School of Medicine of USC in 2010.

Dr. Mayo is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.